Machine Learning-Driven Prognostic Model Integrating Lymphocyte-to-C-Reactive Protein Ratio and TNM Staging in Gallbladder Cancer

结合淋巴细胞/C反应蛋白比值和TNM分期的机器学习驱动胆囊癌预后模型

阅读:2

Abstract

BACKGROUND: A comprehensive preoperative assessment of the patient's physical condition is crucial for predicting the prognosis of patients undergoing radical cholecystectomy for gallbladder cancer (GBC). This study aimed to develop a prognostic model integrating preoperative hematological parameters and clinical information to predict postoperative survival in patients with GBC. METHODS: Patients who underwent radical cholecystectomy for GBC between 2000 and 2024 at Xinhua Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, and Shigatse People's Hospital were included in this study. Data on demographic features, clinical parameters, laboratory results, and clinical outcomes were collected. Univariate and multivariate Cox regression analyses, time-dependent ROC curve analysis, and the least absolute shrinkage and selection operator (LASSO) regression were used to identify the key factors for model development. Various machine learning models were constructed based on these findings. Internal validation assessed model stability, while clinical decision analysis evaluated its practical utility. RESULTS: A total of 184 patients were included, with a mean age of 67 years. Key predictors identified through univariate and multivariate Cox regression, time-dependent ROC, and LASSO analyses were the lymphocyte-to-C-reactive protein ratio (LCR) and tumor-node-metastasis (TNM) staging. The best-performing model was logistic regression, with the following area under the curve (AUC) values: for the training set, 0.785 at 1 year, 0.853 at 2 years, and 0.873 at 3 years; and for the test set, 0.800 at 1 year, 0.870 at 2 years, and 0.872 at 3 years. Clinical decision analysis confirmed the model's clinical applicability. CONCLUSION: The machine learning model incorporating LCR and TNM staging is a robust tool for predicting postoperative survival following radical resection for GBC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。